Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Clin Trials ; 6(6): 618-27, 2009 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-19889888

RESUMEN

BACKGROUND: Even though adverse event (AE) collection and official accounting are mandatory for clinical trials, there are limited detailed guidelines specifying how to summarize the event for reporting in a timely and expeditious manner. This article details the AE and serious adverse event (SAE) reporting summary developed for a large multi-center National Institutes of Health (NIH)-sponsored clinical trial. PURPOSE: To review and analyze the large volume of AE data reported by 10 sites (806 SAEs and 19,034 AEs from August 2000 to May 2007) the automated SAE summary was developed. It was designed to ensure timeliness and clarity in the complex process of AE review and reporting. METHODS: The AE and SAE case report forms (CRFs) as well as the automated SAE summary were developed within a database management system developed by the Data Coordinating Center (DCC) which allowed for web-based data entry at the DCC and 10 sites and offered immediate overall and site-specific reports accessible by the DCC, site, and NIH project staff. RESULTS: The automated SAE summary pulled data from multiple CRFs to create a succinct and informative summary and allowed for prompt and easy reporting to the regulatory agencies. The summary was adaptable to the needs of reviewers because of the availability of multiple search options.


Asunto(s)
Sistemas de Registro de Reacción Adversa a Medicamentos/organización & administración , Antivirales/efectos adversos , Procesamiento Automatizado de Datos/métodos , Hepatitis C Crónica/tratamiento farmacológico , Interferón-alfa/efectos adversos , Polietilenglicoles/efectos adversos , Ensayos Clínicos Controlados Aleatorios como Asunto/métodos , Antivirales/uso terapéutico , Carcinoma Hepatocelular/etiología , Carcinoma Hepatocelular/prevención & control , Sistemas de Administración de Bases de Datos , Progresión de la Enfermedad , Hepatitis C Crónica/complicaciones , Hepatitis C Crónica/mortalidad , Humanos , Interferón alfa-2 , Interferón-alfa/uso terapéutico , Cirrosis Hepática/etiología , Cirrosis Hepática/prevención & control , Fallo Hepático/etiología , Fallo Hepático/prevención & control , Neoplasias Hepáticas/etiología , Neoplasias Hepáticas/prevención & control , Estudios Multicéntricos como Asunto/métodos , National Institutes of Health (U.S.) , Polietilenglicoles/uso terapéutico , Proteínas Recombinantes , Proyectos de Investigación , Estados Unidos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA